Sreeja Biswas

Premium

People

21 October, 2024

o3 Capital's healthcare head quits, to join global advisory major

Mohit Khullar has stepped down as head of healthcare practice at homegrown investment bank o3 Capital and will soon join ......

Premium

General

21 October, 2024

Grapevine: Temasek, Actis, Shadowfax, Swiggy, Sparsh Group, PayU in news

Singapore state investment firm Temasek and private equity firm Actis are making investments in Indian companies while Swiggy and Sparsh ......

Premium

Healthcare

18 October, 2024

Redcliffe Labs CEO Kandoi on IPO timeline, another funding round, and more

Healthtech platform Redcliffe Labs, which recently secured $42 million (Rs 335 crore) in Series C funding, has pushed the timeline for a public ......

Premium

General

18 October, 2024

Grapevine: Zepto, Quadria, TPG, Mensa Brands in news

Quick commerce startup Zepto is in talks to raise $100-150 million (Rs 840-1,260 crore) from domestic family offices and high-net-worth individuals at ......

Premium

Healthcare

08 October, 2024

Searchlight: Can Lifelong Meditech recover after topline falls for a second year?

Lifelong Meditech Ltd, a manufacturer and exporter of disposable medical devices, reported a drop in revenue for the year ended ......

Premium

General

07 October, 2024

Grapevine: Adani eyes Heidelberg's India unit; Saregama may buy into Dharma Productions

Adani Group is in talks to acquire the Indian cement operations of Germany’s Heidelberg Materials, a media report said.  The deal ......

Premium

General

04 October, 2024

Grapevine: IFC may exit Apollo's clinic chain; MUFG renews bid for Yes Bank

Apollo Hospitals Enterprise Ltd plans to sell a significant stake in its subsidiary, Apollo Health & Lifestyle Ltd (AHLL), to ......

Premium

General

03 October, 2024

Grapevine: True North plans an exit; Edelweiss Alts, CarDekho, Afcons in IPO news

Private equity firm True North is considering a complete exit from Shree Digvijay Cement Company, where it holds a 54.83% ......

Premium

Healthcare

27 September, 2024

Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask

Private equity giant KKR is considering a new multi-billion dollar plan to monetise its four-year-old bet on JB Chemicals & ......

Premium

Healthcare

27 September, 2024

What are Carlyle-backed Sequent Scientific's plans after recent merger announcement?

Private equity firm Carlyle-controlled SeQuent Scientific Ltd. aims to establish a larger platform focussed on pure-play animal health portfolio following ......